Sang Jun Yoon

<i>Lactobacillus lactis</i> and <i>Pediococcus pentosaceus</i>‐driven reprogramming of gut microbiome and metabolome ameliorates the progression of non‐alcoholic fatty liver disease

Jeong Seok Yu, Gi Soo Youn, Jieun Choi et al. · Clinical and Translational Medicine · 2021 · 140 citations · Full text

Life Sciences, Biochemistry, Microbiology +14

Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation

Byeong Hyun Min, Shivani Devi, Goo Hyun Kwon et al. · Gut Microbes · 2024 · 136 citations · Full text

Life Sciences, Immunology, Microbiology +13

&lt;i&gt;Lactobacillus&lt;/i&gt; attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis

Na Young Lee, Min Jea Shin, Gi Soo Youn et al. · Clinical and Molecular Hepatology · 2020 · 130 citations · Full text

Life Sciences, Microbiology, Nutritional Sciences +14

<i>Lactobacillus</i>and<i>Pediococcus</i>ameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiome

Na Young Lee, Sang Jun Yoon, Dae Hee Han et al. · Gut Microbes · 2020 · 123 citations · Full text

Life Sciences, Microbiology, Nutritional Sciences +17

Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis

Sang Jun Yoon, Jeong Seok Yu, Byeong Hyun Min et al. · Frontiers in Microbiology · 2023 · 83 citations · Full text

Life Sciences, Microbiology, Nutrition +17